Skip to content

Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT

Bipolar Versus Monopolar Needlescopic En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer: A Prospective Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04839029
Enrollment
200
Registered
2021-04-09
Start date
2019-11-01
Completion date
2022-09-01
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Bladder Neoplasm

Keywords

NMIBC, TURBT, En bloc resection

Brief summary

Non-muscle invasive bladder cancers (NMIBC) compose about 80% of bladder tumors. the stranded treatment of these tumors is TURBT. en bloc resection of NMIBC yields better mascularis propria with better oncological outcomes

Interventions

PROCEDUREBipolar En bloc TURBT

patients subjected to Bipolar resection of bladder tumor by Collins loop

PROCEDUREMonopolar En bloc TURBT

patients subjected to Monopolar resection of bladder tumor by Collins loop (hot Knife)

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* confirmed primary NMIBC (Ta, Tis, T1) * Age \> 18 years

Exclusion criteria

* MIBC * anterior located mass ( difficult or non visualized)

Design outcomes

Primary

MeasureTime frameDescription
Quality of tumor Resectionimmediatly post operativepresence of detrusor muscle
adequacy of tumor Resection2 to 6 weeks postoprativePresence of residual tumor at the bed of previously resected NMIBC

Secondary

MeasureTime frameDescription
Complicationswithin 30 days post-operativeModified Clavien-Dindo classification scale

Countries

Egypt

Contacts

Primary ContactWaleed El-Shaer, M.D
waleed_elshaer@hotmail.com01015767331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026